Cargando…

SARS-CoV-2, long COVID, prion disease and neurodegeneration

Detalles Bibliográficos
Autores principales:	Zhao, Yuhai, Jaber, Vivian R., Lukiw, Walter J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551214/ https://www.ncbi.nlm.nih.gov/pubmed/36238082 http://dx.doi.org/10.3389/fnins.2022.1002770

Ejemplares similares

SARS-CoV-2 Neuroinvasion, Inflammatory Neurodegeneration and Alzheimer's Disease
por: Zhao, Yuhai, et al.
Publicado: (2022)

SARS-CoV-2 Invasion and Pathological Links to Prion Disease
por: Lukiw, Walter J., et al.
Publicado: (2022)

Over-Expressed Pathogenic miRNAs in Alzheimer’s Disease (AD) and Prion Disease (PrD) Drive Deficits in TREM2-Mediated Aβ42 Peptide Clearance
por: Zhao, Yuhai, et al.
Publicado: (2016)

Microbiome-Derived Lipopolysaccharide (LPS) Selectively Inhibits Neurofilament Light Chain (NF-L) Gene Expression in Human Neuronal-Glial (HNG) Cells in Primary Culture
por: Lukiw, Walter J., et al.
Publicado: (2018)

Down-Regulation of Essential Synaptic Components by GI-Tract Microbiome-Derived Lipopolysaccharide (LPS) in LPS-Treated Human Neuronal-Glial (HNG) Cells in Primary Culture: Relevance to Alzheimer’s Disease (AD)
por: Zhao, Yuhai, et al.
Publicado: (2019)

Deficits in the Proline-Rich Synapse-Associated Shank3 Protein in Multiple Neuropsychiatric Disorders
por: Alexandrov, Peter N., et al.
Publicado: (2017)

microRNA-Based Biomarkers in Alzheimer’s Disease (AD)
por: Zhao, Yuhai, et al.
Publicado: (2020)

Gastrointestinal Tract Microbiome-Derived Pro-inflammatory Neurotoxins in Alzheimer’s Disease
por: Zhao, Yuhai, et al.
Publicado: (2021)

Lipopolysaccharide (LPS) Accumulates in Neocortical Neurons of Alzheimer’s Disease (AD) Brain and Impairs Transcription in Human Neuronal-Glial Primary Co-cultures
por: Zhao, Yuhai, et al.
Publicado: (2017)

Secretory Products of the Human GI Tract Microbiome and Their Potential Impact on Alzheimer's Disease (AD): Detection of Lipopolysaccharide (LPS) in AD Hippocampus
por: Zhao, Yuhai, et al.
Publicado: (2017)

Microbiome-Mediated Upregulation of MicroRNA-146a in Sporadic Alzheimer’s Disease
por: Zhao, Yuhai, et al.
Publicado: (2018)

Microbiome-Derived Lipopolysaccharide Enriched in the Perinuclear Region of Alzheimer’s Disease Brain
por: Zhao, Yuhai, et al.
Publicado: (2017)

Deficits in the miRNA-34a-regulated endogenous TREM2 phagocytosis sensor-receptor in Alzheimer's disease (AD); an update
por: Bhattacharjee, Surjyadipta, et al.
Publicado: (2014)

TREM2 signaling, miRNA-34a and the extinction of phagocytosis
por: Zhao, Yuhai, et al.
Publicado: (2013)

Proteostasis unbalance in prion diseases: Mechanisms of neurodegeneration and therapeutic targets
por: Thellung, Stefano, et al.
Publicado: (2022)

Deficiency in the Ubiquitin Conjugating Enzyme UBE2A in Alzheimer’s Disease (AD) is Linked to Deficits in a Natural Circular miRNA-7 Sponge (circRNA; ciRS-7)
por: Zhao, Yuhai, et al.
Publicado: (2016)

Chronic Progressive Neurodegeneration in a Transgenic Mouse Model of Prion Disease
por: Fainstein, Nina, et al.
Publicado: (2016)

Gastrointestinal (GI)-Tract Microbiome Derived Neurotoxins and their Potential Contribution to Inflammatory Neurodegeneration in Alzheimer’s Disease (AD)
por: Lukiw, Walter J., et al.
Publicado: (2021)

SARS-CoV-2, the Angiotensin Converting Enzyme 2 (ACE2) Receptor and Alzheimer’s disease
por: Lukiw, Walter J.
Publicado: (2021)

SARS-CoV-2, COVID-19 and Neurodegeneration
por: Tönges, Lars, et al.
Publicado: (2022)

microRNA-Based Biomarkers and the Diagnosis of Alzheimer’s Disease
por: Zhao, Yuhai, et al.
Publicado: (2015)

Downregulation of Neurofilament Light Chain Expression in Human Neuronal-Glial Cell Co-Cultures by a Microbiome-Derived Lipopolysaccharide-Induced miRNA-30b-5p
por: Pogue, Aileen I., et al.
Publicado: (2022)

microRNA, the Innate-Immune System and SARS-CoV-2
por: Hill, James M., et al.
Publicado: (2022)

Aluminum and its potential contribution to Alzheimer's disease (AD)
por: Bhattacharjee, Surjyadipta, et al.
Publicado: (2014)

SARS-CoV-2 Infectivity and Neurological Targets in the Brain
por: Lukiw, Walter J., et al.
Publicado: (2020)

miRNAs and viroids utilize common strategies in genetic signal transfer
por: Hill, James M., et al.
Publicado: (2014)

microRNA-34a (miRNA-34a) Mediated Down-Regulation of the Post-synaptic Cytoskeletal Element SHANK3 in Sporadic Alzheimer's Disease (AD)
por: Zhao, Yuhai, et al.
Publicado: (2019)

Pathogenic microbes, the microbiome, and Alzheimer’s disease (AD)
por: Hill, James M., et al.
Publicado: (2014)

microRNA Heterogeneity, Innate-Immune Defense and the Efficacy of SARS-CoV-2 Infection—A Commentary
por: Lukiw, Walter J.
Publicado: (2021)

Lipopolysaccharides (LPSs) as Potent Neurotoxic Glycolipids in Alzheimer’s Disease (AD)
por: Zhao, Yuhai, et al.
Publicado: (2022)

Increase in NF-κB-sensitive miRNA-146a and miRNA-155 in multiple sclerosis (MS) and pro-inflammatory neurodegeneration
por: Devier, Deidre J., et al.
Publicado: (2015)

SARS‐CoV‐2, aging, and Post‐COVID‐19 neurodegeneration
por: Strong, Michael J.
Publicado: (2022)

Facilitation of Gastrointestinal (GI) Tract Microbiome-Derived Lipopolysaccharide (LPS) Entry Into Human Neurons by Amyloid Beta-42 (Aβ42) Peptide
por: Lukiw, Walter J., et al.
Publicado: (2019)

microRNA-146a Signaling in Alzheimer's Disease (AD) and Prion Disease (PrD)
por: Lukiw, Walter J.
Publicado: (2020)

Endogenous miRNA-Based Innate-Immunity against SARS-CoV-2 Invasion of the Brain
por: Lukiw, Walter J., et al.
Publicado: (2023)

Aluminum-Induced Amyloidogenesis and Impairment in the Clearance of Amyloid Peptides from the Central Nervous System in Alzheimer’s Disease
por: Zhao, Yuhai, et al.
Publicado: (2014)

Can SARS-CoV-2 Infection Lead to Neurodegeneration and Parkinson’s Disease?
por: Krey, Lea, et al.
Publicado: (2021)

Alteration of Biomolecular Conformation by Aluminum-Implications for Protein Misfolding Disease
por: Zhao, Yuhai, et al.
Publicado: (2022)

Recent Advances in Our Molecular and Mechanistic Understanding of Misfolded Cellular Proteins in Alzheimer’s Disease (AD) and Prion Disease (PrD)
por: Lukiw, Walter J.
Publicado: (2022)

Regulating amyloidogenesis through the natural triggering receptor expressed in myeloid/microglial cells 2 (TREM2)
por: Jones, Brandon M., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_j21q1po68h4bhv9tp0njegtmbg